Ocular Manifestations of Biopsy-Proven Pulmonary Sarcoidosis in Korea

Table 3

Comparison of uveitis patients with biopsy-confirmed pulmonary sarcoidosis by initial manifestation.

	Ocular manifestation first group ()	Extraocular manifestation first group ()	value
Mean age	57.4 ± 15.3	54.1 ± 12.0	0.45
Female/male ratio	17/1 (94.4%)	18/3 (85.7%)	0.61
BHL^a in radiography	15 (83.3%)	19 (90.5%)	0.65
Increased ACE^b	13 (72.2%)	16 (76.2%)	0.78
ACE^b level	82.4 ± 46.5	72.6 ± 36.0	0.47
Ocular complications	4 (22.2%)	5 (23.8%)	0.61
Visual acuity at last visit	0.83 ± 0.19	0.90 ± 0.14	0.15
Ocular involvement
Mutton-fat KP^c	16 (88.9%)	14 (66.7%)	0.10
Angle change	2 (11.1%)	3 (14.3%)	0.58
Vitreous opacity	5 (27.8%)	5 (23.8%)	0.53
Nodular phlebitis	13 (72.2%)	13 (61.9%)	0.37
Multiple choroidal lesions	7 (38.9%)	6 (28.6%)	0.36
Optic disc lesion	3 (16.7%)	5 (23.8%)	0.44
Bilaterality	16 (88.9%)	13 (61.9%)	0.07
Systemic treatment	16 (88.9%)	12 (57.1%)	0.037
Immunosuppression	10 (55.6%)	4 (19.0%)	0.018

^aBilateral hilar lymphadenopathy; ^bangiotensin-converting enzyme; ^ckeratic precipitate.